CD152 Rabbit Polyclonal Antibody
CD152 Rabbit Polyclonal Antibody
![]() CD152 Polyclonal Antibody |
|||
ES8684-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against CD152 from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
![]() CD152 Polyclonal Antibody |
|||
46815-100ul | SAB | 100ul | 302.4 EUR |
![]() CD152 Polyclonal Antibody |
|||
46815-50ul | SAB | 50ul | 224.4 EUR |
![]() CD152 antibody |
|||
10R-CD152aMS | Fitzgerald | 500 ug | 444 EUR |
Description: Hamster monoclonal CD152 antibody |
|||
![]() CD152 antibody |
|||
10R-CD152bMS | Fitzgerald | 500 ug | 444 EUR |
Description: Hamster monoclonal CD152 antibody |
|||
![]() CD152 |
|||
MO152A(V100) | ImmunoStep | 100 ug | 60 EUR |
![]() CD152 |
|||
MO152A(V25) | ImmunoStep | 25 ug | 60 EUR |
![]() CD152 |
|||
MO152B(V100) | ImmunoStep | 100 ug | 60 EUR |
![]() CD152 |
|||
MO152B(V25) | ImmunoStep | 25 ug | 60 EUR |
![]() CD152 |
|||
MO152CFB(V100) | ImmunoStep | 100 ug | 60 EUR |
![]() CD152 |
|||
MO152CFB(V25) | ImmunoStep | 25 ug | 60 EUR |
![]() CD152 |
|||
MO152F(V100) | ImmunoStep | 100 ug | 60 EUR |
![]() CD152 |
|||
MO152F(V25) | ImmunoStep | 25 ug | 60 EUR |
![]() CD152 |
|||
MO152F(V500) | ImmunoStep | 500 ug | 60 EUR |
![]() CD152 |
|||
MO152PE(V100) | ImmunoStep | 100 ug | 60 EUR |
![]() CD152 |
|||
MO152PE(V25) | ImmunoStep | 25 ug | 60 EUR |
![]() CD152 |
|||
MO152PP(V100) | ImmunoStep | 100 ug | 60 EUR |
![]() CD152 |
|||
MO152PP(V25) | ImmunoStep | 25 ug | 60 EUR |
![]() CD152 |
|||
MO152PP5.5(V100) | ImmunoStep | 100 ug | 60 EUR |
![]() CD152 |
|||
MO152PP5.5(V25) | ImmunoStep | 25 ug | 60 EUR |
![]() CD152 |
|||
MO152PU(V100) | ImmunoStep | 100 ug | 60 EUR |
![]() CD152 |
|||
MO152PU(V500) | ImmunoStep | 500 ug | 60 EUR |
![]() CD152 antibody (PE) |
|||
61R-1314 | Fitzgerald | 100 ug | 424.8 EUR |
Description: Mouse monoclonal CD152 antibody (PE) |
|||
![]() CD152 antibody (biotin) |
|||
61R-CD152aMSBT | Fitzgerald | 500 ug | 535.2 EUR |
Description: Hamster monoclonal CD152 antibody (biotin) |
|||
![]() CD152 antibody (FITC) |
|||
61R-CD152aMSFT | Fitzgerald | 500 ug | 548.4 EUR |
Description: Hamster monoclonal CD152 antibody (FITC) |
|||
![]() CD152 antibody (PE) |
|||
61R-CD152aMSPE | Fitzgerald | 100 ug | 360 EUR |
Description: Hamster monoclonal CD152 antibody (PE) |
|||
![]() CD152 Antibody (FITC) |
|||
abx133968-100Assays | Abbexa | 100 Assays | 526.8 EUR |
![]() CD152 Antibody (FITC) |
|||
abx133968-50Assays | Abbexa | 50 Assays | 410.4 EUR |
![]() CD152 Antibody (Biotin) |
|||
20-abx200697 | Abbexa |
|
|
![]() CD152 Antibody (FITC) |
|||
20-abx200699 | Abbexa |
|
|
![]() Anti-CD152 Antibody |
|||
A00020 | BosterBio | 100ul | 476.4 EUR |
Description: Rabbit Polyclonal Antibody for CD152 Antibody (CTLA4) detection.tested for IHC in Human. |
|||
![]() Anti-CD152 antibody |
|||
STJ16100529 | St John's Laboratory | 200 µg | 1023.6 EUR |
![]() Anti-CD152 antibody |
|||
STJ98747 | St John's Laboratory | 200 µl | 236.4 EUR |
Description: Rabbit polyclonal to CD152. |
|||
![]() Anti-CD152 Antibody |
|||
A1388-100 | Biovision | each | 444 EUR |
![]() CD152 antibody (Azide Free) |
|||
10R-CD152aMSP | Fitzgerald | 500 ug | 548.4 EUR |
Description: Hamster monoclonal CD152 antibody (Azide Free) |
|||
![]() CD152 antibody (Azide Free) |
|||
10R-CD152bMSP | Fitzgerald | 500 ug | 548.4 EUR |
Description: Hamster monoclonal CD152 antibody (Azide Free) |
|||
![]() CD152 (CTLA-4) Antibody |
|||
abx021366-02mg | Abbexa | 0.2 mg | 1220.4 EUR |
![]() CTLA-4 Antibody / CD152 |
|||
R32809 | NSJ Bioreagents | 100 ug | 419 EUR |
![]() CTLA-4 Antibody / CD152 |
|||
RQ5483 | NSJ Bioreagents | 100 ul | 419 EUR |
![]() CTLA-4 Antibody / CD152 |
|||
RQ6465 | NSJ Bioreagents | 100ug | 419 EUR |
Description: CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4), also known as CD152, is a protein receptor that down regulates the immune system. It is a member of the immunoglobulin superfamily, which is expressed on the surface of Helper T cells and transmits an inhibitory signal to T cells. CTLA4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells. CTLA4 transmits an inhibitory signal to T cells, whereas CD28 transmits a stimulatory signal. Blockade of CTLA4 expression in vitro augmented HIV-specific CD4-positive T-cell function. |
|||
![]() CTLA-4 Antibody / CD152 |
|||
V7700-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
|||
![]() CTLA-4 Antibody / CD152 |
|||
V7700-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
|||
![]() CTLA-4 Antibody / CD152 |
|||
V7700SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This CTLA4 antibody is specific to the soluble form of the protein. CTLA4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. It contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases.The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule. |
|||
![]() Anti-CTLA4 (CD152) Monoclonal Antibody |
|||
M00020 | BosterBio | 100ug | 476.4 EUR |
Description: Rabbit Monoclonal CTLA4 (CD152) Antibody. Validated in IF, ICC, WB and tested in Human, Mouse, Rat. |
|||
![]() Anti-CTLA4 (CD152) Neutralizing Antibody |
|||
71212 | BPS Bioscience | 100 µg | 490 EUR |
Description: Neutralizing recombinant human monoclonal antibody recognizing the extracellular domain of CTLA4 and blocking binding of CTLA4 to B7.1 and B7.2. This antibody recognizes human CTLA4 but does not bind to murine CTLA4. This antibody has not been tested for cross-reactivity with other species. |
|||
![]() Anti-Hu CD152 PE |
|||
1P-785-T025 | ExBio | 25 tests | 168 EUR |
![]() Anti-Hu CD152 PE |
|||
1P-785-T100 | ExBio | 100 tests | 288 EUR |
![]() Anti-Hu CD152 Purified |
|||
11-785-C025 | ExBio | 0.025 mg | 118.8 EUR |
![]() Anti-Hu CD152 Purified |
|||
11-785-C100 | ExBio | 0.1 mg | 189.6 EUR |
![]() Anti-Hu CD152 APC |
|||
1A-785-T100 | ExBio | 100 tests | 288 EUR |
![]() CTLA4 (CD152), Fc fusion |
|||
71149-1 | BPS Bioscience | 100 µg | 150 EUR |
Description: Human secreted CTLA4 , Fc fusion protein, also known as Cytotoxic T-lymphocyte-associated protein 4 and CD152. GenBank Accession No. NM_005214, a.a. 36-162 expressed in a HEK293 cell expression system. MW = 40.3 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
|||
![]() Hamster Anti Mouse Cd152 Monoclonal Antibody |
|||
CABT-47114HM | Creative Diagnostics | 0.1 mg | 546 EUR |
![]() Hamster Anti CTLA-4 (CD152) Antibody |
|||
20-abx137133 | Abbexa |
|
|
![]() Purified Anti-human CD152 Antibody *BN13* |
|||
11520000 | AAT Bioquest | 100 ug | 164 EUR |
![]() APC Anti-human CD152 Antibody *BN13* |
|||
115201C0 | AAT Bioquest | 25 tests | 179 EUR |
![]() APC Anti-human CD152 Antibody *BN13* |
|||
115201C1 | AAT Bioquest | 100 tests | 505 EUR |
![]() APC Anti-human CD152 Antibody *BN13* |
|||
115201C2 | AAT Bioquest | 500 tests | 1887 EUR |
![]() FITC Anti-human CD152 Antibody *BN13* |
|||
115201H0 | AAT Bioquest | 100 tests | 245 EUR |
![]() FITC Anti-human CD152 Antibody *BN13* |
|||
115201H1 | AAT Bioquest | 500 tests | 918 EUR |
![]() TRITC Anti-human CD152 Antibody *BN13* |
|||
115201I0 | AAT Bioquest | 100 tests | 245 EUR |
![]() TRITC Anti-human CD152 Antibody *BN13* |
|||
115201I1 | AAT Bioquest | 500 tests | 918 EUR |
![]() PacBlue Anti-human CD152 Antibody *BN13* |
|||
115201J0 | AAT Bioquest | 100 tests | 245 EUR |
![]() PacBlue Anti-human CD152 Antibody *BN13* |
|||
115201J1 | AAT Bioquest | 500 tests | 918 EUR |
![]() PacOrange Anti-human CD152 Antibody *BN13* |
|||
115201K0 | AAT Bioquest | 100 tests | 245 EUR |
![]() PacOrange Anti-human CD152 Antibody *BN13* |
|||
115201K1 | AAT Bioquest | 500 tests | 918 EUR |
![]() PE Anti-human CD152 Antibody *BN13* |
|||
115201L0 | AAT Bioquest | 25 tests | 179 EUR |
![]() PE Anti-human CD152 Antibody *BN13* |
|||
115201L1 | AAT Bioquest | 100 tests | 505 EUR |
![]() PE Anti-human CD152 Antibody *BN13* |
|||
115201L2 | AAT Bioquest | 500 tests | 1887 EUR |
![]() PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T0 | AAT Bioquest | 25 tests | 179 EUR |
![]() PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T1 | AAT Bioquest | 100 tests | 505 EUR |
![]() PerCP Anti-human CD152 Antibody *BN13* |
|||
115201T2 | AAT Bioquest | 500 tests | 1887 EUR |
![]() Mouse Anti Human Cd152 Monoclonal Antibody,RPE |
|||
CABT-47107MH | Creative Diagnostics | 100 TEST | 1008 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx133970 | Abbexa |
|
|
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx139385-01mg | Abbexa | 0.1 mg | 427.2 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx139386-01mg | Abbexa | 0.1 mg | 427.2 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx200703 | Abbexa |
|
|
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
20-abx225129 | Abbexa |
|
|
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414772-025mg | Abbexa | 0.25 mg | 678 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414773-05mg | Abbexa | 0.5 mg | 994.8 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx414774-01mg | Abbexa | 0.1 mg | 526.8 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx413284-02mg | Abbexa | 0.2 mg | 811.2 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody |
|||
abx413702-025mg | Abbexa | 0.25 mg | 678 EUR |
![]() APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D0 | AAT Bioquest | 25 tests | 210 EUR |
![]() APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D1 | AAT Bioquest | 100 tests | 587 EUR |
![]() APC/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201D2 | AAT Bioquest | 500 tests | 1989 EUR |
![]() PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M0 | AAT Bioquest | 25 tests | 210 EUR |
![]() PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M1 | AAT Bioquest | 100 tests | 587 EUR |
![]() PE/Cy5 Anti-human CD152 Antibody *BN13* |
|||
115201M2 | AAT Bioquest | 500 tests | 1989 EUR |
![]() PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N0 | AAT Bioquest | 25 tests | 210 EUR |
![]() PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N1 | AAT Bioquest | 100 tests | 587 EUR |
![]() PE/Cy7 Anti-human CD152 Antibody *BN13* |
|||
115201N2 | AAT Bioquest | 500 tests | 1989 EUR |
![]() PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U0 | AAT Bioquest | 25 tests | 210 EUR |
![]() PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U1 | AAT Bioquest | 100 tests | 587 EUR |
![]() PerCP/Cy5.5 Anti-human CD152 Antibody *BN13* |
|||
115201U2 | AAT Bioquest | 500 tests | 1989 EUR |
![]() Anti-Hu CD152 Alexa Fluor647 |
|||
A6-785-T100 | ExBio | 100 tests | 322.8 EUR |
![]() CD152 [CTLA-4] Recombinant Protein |
|||
90-411 | ProSci | 100 ug | 342.6 EUR |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
|||
![]() CD152 [CTLA-4] Recombinant Protein |
|||
90-412 | ProSci | 500 ug | 556.8 EUR |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
|||
![]() CD152 [CTLA-4] Recombinant Protein |
|||
90-415 | ProSci | 100 ug | 437.1 EUR |
Description: CD152 [CTLA-4] and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4 + and CD8 + T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4 + T cells and 50% of CD8 + T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
|||
![]() CD152 [CTLA-4] Recombinant Protein |
|||
90-416 | ProSci | 100 ug | 374.1 EUR |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
|||
![]() CD152 [CTLA-4] Recombinant Protein |
|||
90-417 | ProSci | 500 ug | 588.3 EUR |
Description: CD152 and CD28, together with their ligands B7-1 and B7-2, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CD152 and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain. CD152 and CD28 are both expressed on the cell surface as disulfide-linked homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28. |
|||
![]() Anti-Hu CD152 PE-Cy7 |
|||
T7-785-T100 | ExBio | 100 tests | 321.6 EUR |
![]() Anti-Hu CD152 PE-Cy5 |
|||
T8-785-T100 | ExBio | 100 tests | 288 EUR |
![]() CTLA4 /CD152 (Human) ELISA Kit |
|||
K4157-100 | Biovision | each | 992.4 EUR |
![]() CTLA4 (CD152), Fc fusion (Human) |
|||
71149-2 | BPS Bioscience | 1 mg | 1200 EUR |
Description: Human secreted CTLA4 , Fc fusion protein, also known as Cytotoxic T-lymphocyte-associated protein 4 and CD152. GenBank Accession No. NM_005214, a.a. 36-162 expressed in a HEK293 cell expression system. MW = 40.3 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
|||
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx133969-100Assays | Abbexa | 100 Assays | 594 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx133969-50Assays | Abbexa | 50 Assays | 477.6 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PE) |
|||
abx139387-100tests | Abbexa | 100 tests | 577.2 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (APC) |
|||
20-abx200696 | Abbexa |
|
|
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (PerCP) |
|||
20-abx200701 | Abbexa |
|
|
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (RPE) |
|||
abx413285-100tests2ml | Abbexa | 100 tests (2 ml) | 710.4 EUR |
![]() Cytotoxic T-Lymphocyte Protein 4 (CD152) Antibody (RPE) |
|||
abx413286-25tests | Abbexa | 25 tests | 376.8 EUR |
![]() Anti-CD152/ CTLA-4 Antibody [BNI3], Unconjugated-100ug |
|||
QAB59-100ug | EnQuireBio | 100ug | 240 EUR |
![]() Anti-CD152/ CTLA-4 Antibody [BNI3], APC-100Tests |
|||
QAB59-APC-100Tests | EnQuireBio | 100Tests | 422.4 EUR |
![]() Anti-CD152/ CTLA-4 Antibody [BNI3], APC-25Tests |
|||
QAB59-APC-25Tests | EnQuireBio | 25Tests | 188.4 EUR |
![]() Anti-CD152/ CTLA-4 Antibody [BNI3], PE-100Tests |
|||
QAB59-PE-100Tests | EnQuireBio | 100Tests | 310.8 EUR |
![]() Anti-CD152/ CTLA-4 Antibody [BNI3], PE-25Tests |
|||
QAB59-PE-25Tests | EnQuireBio | 25Tests | 178.8 EUR |
![]() iFluor® 350 Anti-human CD152 Antibody *BN13* |
|||
11520010 | AAT Bioquest | 100 tests | 245 EUR |
![]() iFluor® 350 Anti-human CD152 Antibody *BN13* |
|||
11520011 | AAT Bioquest | 500 tests | 918 EUR |
![]() iFluor® 405 Anti-human CD152 Antibody *BN13* |
|||
11520020 | AAT Bioquest | 100 tests | 245 EUR |
![]() iFluor® 405 Anti-human CD152 Antibody *BN13* |
|||
11520021 | AAT Bioquest | 500 tests | 918 EUR |
![]() iFluor® 430 Anti-human CD152 Antibody *BN13* |
|||
11520030 | AAT Bioquest | 100 tests | 245 EUR |
![]() iFluor® 430 Anti-human CD152 Antibody *BN13* |
|||
11520031 | AAT Bioquest | 500 tests | 918 EUR |
![]() iFluor® 450 Anti-human CD152 Antibody *BN13* |
|||
11520040 | AAT Bioquest | 100 tests | 245 EUR |
![]() iFluor® 450 Anti-human CD152 Antibody *BN13* |
|||
11520041 | AAT Bioquest | 500 tests | 918 EUR |
![]() iFluor® 488 Anti-human CD152 Antibody *BN13* |
|||
11520050 | AAT Bioquest | 100 tests | 245 EUR |
![]() iFluor® 488 Anti-human CD152 Antibody *BN13* |
|||
11520051 | AAT Bioquest | 500 tests | 918 EUR |
![]() iFluor® 514 Anti-human CD152 Antibody *BN13* |
|||
11520060 | AAT Bioquest | 100 tests | 245 EUR |
CD152 Rabbit Polyclonal Antibody